Biotechnology Market: Global Industry Analysis and Forecast (2021-2029)

Biotechnology Market was valued at US$ 16.83. in 2021. Global Biotechnology Market size is expected to grow at a CAGR of 8.7% through the forecast period.
Biotechnology Market Overview:
Biotechnology is an interdisciplinary, inventive field that uses living organisms, biological systems, or derivatives to modify or develop cycles and solutions for creating medical care related items and therapeutics. It significantly impacts on various areas like medicine and drugs, genomics, food and synthetics, and others. It has extensive and huge use in solving critical challenges related to health and prosperity, food and energy supply, and ecological safety.



To know about the Research Methodology :- Request Free Sample Report

Due to the rise of the biotechnology area in developing countries like China, Japan, and India, the market is being driven by positive government drives. The government authority activities are pointed toward smoothing out the drug administrative pathway, normalizing clinical investigations, improving repayment strategies, and assisting the item endorsement process, all of which will furnish the business with worthwhile development potential.

2021 is considered as a base year to forecast the market from 2022 to 2029. 2021’s market size is estimated on real numbers and outputs of the key players and major players across the globe. Past five years trends are considered while forecasting the market through 2029. 2021 is a year of exception and analysis especially with the impact of lockdown by region.
Biotechnology Market Dynamics:
Market Drivers:

The developing traction of customized medication and a rising number of orphan medication details are opening new roads for biotechnology applications and are driving the influx of arising and imaginative biotechnology organizations, further helping the market development. Growing advancements in life sciences are offering various advantages related with medical services mediations and efficiency by consolidating creative innovation. Advancement of inventive methods and their execution by the organizations influences the biotech area emphatically and is visualized to massive development of the market. Imaginative advancements including 3D bio-printing are being utilized in medication. 3D bio-printing utilizes living cells to foster specific organs of human body including heart valves, ligament and skin. It can possibly foster medications as well as tissues, organs, like liver and heart utilizing patient's body cells.

The capacity to make human cells and tissues will additionally broaden the scope of uses in clinical exploration by giving exact models to study and examination. Likewise, headways in clinical innovation have prompted consolidation of biosensors, one more creative innovation utilized for checking individual wellbeing. Biosensors are intended to screen a few bio-signatures, for example, beat, pulse, internal heat level and others. This innovation works with remote-patient checking and helps the medical services experts by giving them fundamental wellbeing data. Moreover, the biotech associations are focusing on the advancement of smart technology and their usage by teaming up with individuals on the lookout. Huge organizations with government sponsored affiliation show money related help to aid R&D activities and novel item improvisation attempts.

Significant key players are researching and creating pipeline items for diabetes and neurological problems, like Parkinson's and Alzheimer's sicknesses, different kinds of malignant growths, and cardiovascular infections. Life sciences and medical services areas are encountering a far reaching utilization of maturation innovation and have decidedly influenced the market development. Several modifications & advancements in the regular bioreactors like, the presentation of rearranged bioreactors and vortex bioreactors have prompted enhancements in the maturation innovation and development in its adoption. Such examinations may spike further exploration possibilities in this area and drive the market. Biotechnological strategies including undifferentiated cell innovation, DNA fingerprinting, and hereditary designing, among others, are building up some forward movement during the forecast period. Mechanical headway in immature microorganism therapeutics, expanding interest for biologics, and a developing focus on the improvement of customized medications has brought about a developing business sector for undeveloped cell advances. DNA fingerprinting applications are on the ascent in criminological science, and for the examination of family connections in creature populaces as well as the estimation of the degree of inbreeding. Additionally, hereditary designing and cloning strategies are progressively utilized in animal breeding and for the assembling of perplexing biological substances.

Market Restraints:

Biotechnology and related items have to meet administrative rules and standards. The significant regulatory bodies in the U.S., answerable for monitoring essential parameters are the Animal and Plant Health Inspection Service (APHIS), the U.S. Natural Protection Agency (EPA), and the U.S. Division of Health and Human Services' Food and Drug Administration (FDA). The Co-ordinated Framework for Regulation of Biotechnology shows the government framework for appraisal of items planned using present day biotechnology. This structure depends after existing regulations created to safeguard general safety and the climate. Drugs or substance not following the regulations or causing harm to the environment are not allowed to launch into the market.

The U.S. government has laid out new strategies, guidelines, and compliances to carry out regulations for biotech items. The FDA screens security and adequacy of drug items, human food and creature feed. EPA screens pesticides, including plants containing plant-consolidated protectants to get public wellbeing. Furthermore, the APHIS with the assistance of its Biotechnology Regulatory Services (BRS) program, directs improvement of explicit life forms created utilizing hereditary designing that might possibly represent a gamble to populace wellbeing. Consequently, the biotechnology items and administrations are controlled by a large group of administrative specialists that may lull the turn of events and commercialization of the items. Moreover, certain measure of chance connected with hereditary information might prevent the biotech business development. Thus stringent government regulations can be a restraining factor for the biotechnology market. Also the biotechnological products are costlier compared to the synthetic products. Hence this can be another restraining factor for the biotechnology market.
Biotechnology Market Segment Analysis:
The nanobiotechnology segment will develop at the quickest rate during the forecast period attributable to an expansion in nanomedicine endorsements and the appearance of cutting edge innovation. For example, uses of theranostics nanoparticles have acquired catalyst for empowering brief determination and customization of treatment choices for various issues on the double. Factors, like low harmfulness, more modest size, and synthetic versatility of nanoparticles have ended up being useful for defeating the restriction related with ordinary courses of conventional medication organization. Besides, tissue designing and recovery medication held a critical offer because of government and confidential interests in the field, alongside high medical services spending and presence of a significant key players here.

These elements are supposed to drive the segment development over the forecast period. DNA sequencing innovation drove the market and represented the largest income share due to declining sequencing expenses and rising entrance of advance DNA sequencing procedures. Government subsidizing in hereditary examination has empowered an ascent in uses of sequencing for a superior comprehension of illnesses.



Based on the application, the wellbeing application segment dominated the market and will continue to be the main segment all through the forecast period. Developing illness trouble, expanding accessibility of agri-biotech and bio-administrations, and mechanical improvements in the bio-modern area will drive the segment development. The segment development is likewise energized by huge headways in the fields of Artificial Intelligence (AI), AI, and enormous information, which are supposed to build entrance of bioinformatics applications, particularly in businesses, like food and drinks.

Additionally, cooperative endeavours and associations focused on the turn of events and commercialization of new remedial stages and particles are expected to drive market development. For example, in January 2021, Novartis worked together with Alnylam for investigating the utilization of the last's siRNA innovation for the improvement of designated treatment for the reclamation of liver capability. Essentially, in September 2021, AstraZeneca and VaxEquity teamed up on the turn of events and commercialization of a self-enhancing RNA therapeutics stage to investigate novel helpful projects. Besides, the developing interest for biosimilars and rising uses of accuracy medication is supposed to support segment development during the forecast period.
Biotechnology Market Regional Insights:
The North America region dominated the market with 44.20 % share in 2021. The regional market is seeing development because of a few elements, like the presence of major participants, broad R&D exercises, and high medical services utility. The region has a high infiltration of genomics, proteomics, and cell science based stage that is speeding up the reception of life sciences devices. Moreover, the increase in pervasiveness of chronic disease and rising reception of customized medication applications for the therapy of chronic disease will positively affect the market development in the region.

The Asia Pacific region is expected to witness significant growth at a CAGR of 4.7% through the forecast period. The development of the regional market can be credited to increasing speculations and improvement in medical services foundation, great government drives, and extension systems from key market players. For example, in February 2022, Moderna Inc. reported its arrangements for a geographic development of its business network in Asia through the launch of four new auxiliaries in Malaysia, Singapore, Hong Kong, and Taiwan. Also, biopharmaceutical joint efforts, like Kiniksa Pharmaceuticals and Huadong Medicine's essential cooperation for the turn of events and commercialization of Kiniksa's ARCALYST and mavrilimumab in the Asia Pacific region will drive the market development.

The objective of the report is to present a comprehensive analysis of the global Biotechnology market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.

PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The reports also help in understanding the Biotechnology Market dynamic, structure by analyzing the market segments and projecting the Biotechnology Market Market size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Biotechnology Market make the report investor’s guide.
Biotechnology Market Scope: Inquire before buying



Global Biotechnology Market


Report Coverage
Details


Base Year:
2021
Forecast Period:
2022-2029


Historical Data:
2017 to 2021
Market Size in 2021:
US$ 16.83 Bn.


Forecast Period 2022 to 2029 CAGR:
8.7%
Market Size in 2029:
US$ 25.86 Bn.


 Segments Covered:
by Technology
• Nanobiotechnology
• Tissue Engineering & Regeneration
• DNA Sequencing
• Cell-based Assays
• Fermentation
• Others


by Application
• Nanobiotechnology
• Tissue Engineering & Regeneration
• DNA Sequencing
• Cell-based Assays
• Fermentation
• Others



Biotechnology Market by Region
• North America
• Europe
• Asia Pacific
• South America
• Middle East and Africa
Biotechnology Market Key Players
• AstraZeneca (UK)
• Gilead Sciences, Inc. (USA)
• Bristol-Myers Squibb (USA)
• Biocon (India)
• Sanofi (France)
• Biogen (USA)
• Abbott Laboratories (USA)
• Pancea Biotech (India)
• Pfizer, Inc. (USA)
• Amgen, Inc. (USA)
• Bharat Biotech (India)
• Novo Nordisk A/S (Denmark)
• Merck KGaA (USA)
• Johnson & Johnson Services, Inc. (USA)
• Novartis AG (USA)
• F. Hoffmann-La Roche Ltd. (Russia)
• Lonza (Switzerland)

Frequently Asked Questions:

1] What segments are covered in the Biotechnology Market report?
Ans. The segments covered in the Biotechnology Market report are based on Technology and Application.

2] Which region is expected to hold the highest share in the Biotechnology Market?
Ans. The Asia Pacific region is expected to hold the highest share in the Biotechnology Market

3] What is the market size of the Biotechnology Market by 2029?
Ans. The market size of the Biotechnology Market by 2029 is expected to reach US$ 25.86 Bn.

4] What is the forecast period for the Biotechnology Market?
Ans. The forecast period for the Biotechnology Market is 2022-2029.

5] What was the market size of the Global Biotechnology Market in 2021?
Ans. The market size of the Biotechnology Market in 2021 was valued at US$ 16.83 Bn.